Law ❯ Intellectual Property ❯ Patent Law

Pharmaceutical Patents

Generic Drugs Novo Nordisk Patent Settlements Patent Infringement Pfizer Case Covid-19 Vaccine Patents Biosimilars Litigation Patent Expiration Patent Disputes

Supreme Court Hears Hikma v. Amarin, Tests Limits of 'Skinny Label' Liability

Questions hinted at a narrow path that preserves generic entry under existing inducement law.

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

Moderna Reaches Up to $2.25 Billion LNP Patent Settlement, Pays $950 Million Upfront

Mexican Court Revives Denosumab Patent, Extends Amgen Exclusivity to 2027

Delhi High Court Allows Zydus to Market Nivolumab Biosimilar on Public‑Interest Grounds

Brazil’s Superior Court of Justice Rejects Semaglutide Patent Extension, Paving Way for 2026 Generics

WHO Endorses Long-Term GLP-1 Use for Obesity as Indian Ruling Opens Production and Safety Alerts Expand

Supreme Court Rejects Roche Bid to Halt Natco’s Risdiplam Sales

Delhi High Court Rejects Roche Appeal, Clears Natco’s ₹15,900 Generic Risdiplam